Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Study:

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications

Rationale:

n/a

Purpose:

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Study Status: Recruiting

Recruiting:
Matt Kalaycio, MD kalaycm@ccf.org

Condition Intervention Phase
Hematological Malignancies
Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders
Hurler Syndrome (MPS I)
Krabbe Disease (Globoid Leukodystrophy)
X-linked Adrenoleukodystrophy
Primary Immunodeficiency Diseases
Bone Marrow Failure
Beta-thalassemia
Drug: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) N/A

Verified by Center for International Blood and Marrow Transplant Research January, 2014

Sponsored by: Center for International Blood and Marrow Transplant Research
Information provided by: Center for International Blood and Marrow Transplant Research
ClinicalTrials.gov identifier: NCT01351545

Study Type: Interventional

Study Design: Time Perspective: Prospective

Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site